Cardiovascular risk reduction - quality prescribing guidance 2026-2029: consultation

Glossary of Terms

The following terms are used in this consultation:

ABPM Ambulatory Blood Pressure Monitoring

ACE Angiotensin Converting Enzyme

ACR Albumin-to-Creatinine Ratio

ADR Adverse Drug Reaction

AF Atrial Fibrillation

AKI Acute Kidney Injury

ALP Alkaline Phosphatase

ALT Alanine Aminotransferase

ARB Angiotensin II Receptor Antagonist

ASCVD Atherosclerotic Cardiovascular Disease

ASSIGN ASsessing cardiovascular risk using SIGN guidelines to assign preventive treatment

AST Aspartate Aminotransferase

BIHS British and Irish Hypertension Society

BMI Body Mass Index

BMS British Menopause Society

BNF British National Formulary

BP Blood Pressure

BRAN Benefits, Risks, Alternatives, Nothing

CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk

CHD Coronary Heart Disease

CK Creatine Kinase

CKD Chronic Kidney Disease

CKD eGFR Chronic Kidney Disease Estimated Glomerular Filtration Rate

CV Cardiovascular

CVD Cardiovascular Disease

DBP Diastolic Blood Pressure

DKA Diabetic Ketoacidosis

DPP-4 Dipeptidyl Peptidase 4

ECG Electrocardiogram

eGFR Estimated Glomerular Filtration Rate

EMIS Egton Medical Information Systems – a clinical IT system

FH Familial hypercholesterolaemia

g Gram (unit of measurement)

GGT Gamma-Glutamyl Transferase

GIP Glucose-dependent Insulinotropic Polypeptide

GIP-RA Glucose-dependent Insulinotropic Polypeptide Receptor Agonists

GLP-1 Glucagon-Like Peptide-1

GLP-1RA Glucagon-Like Peptide-1 Receptor Agonists

GP General Practitioner

HbA1C Glycated Haemoglobin

HBPM Home Blood Pressure Monitoring

HCC Hepatocellular Carcinoma

HCP Healthcare Professionals

HDL High-density Lipoprotein

HDL-C High-Density Lipoprotein Cholesterol

HF Heart Failure

HMUD Hospital Medicines Utilisation Database

HRT Hormone Replacement Therapy

HSCP Health and Social Care Partnership

IHD Ischaemic Heart Disease

Kcal Kilocalorie

kg/m² Kilograms per square Metre

LDL Low-density Lipoprotein

LDL-C Low-Density Lipoprotein Cholesterol

LFTs Liver Function Tests

LVSD Left Ventricular Systolic Dysfunction

MASLD Metabolic dysfunction-Associated Steatotic Liver Disease

mg Milligram (unit of measurement)

MHRA Medicines and Healthcare products Regulatory Agency

MI Myocardial Infarction

mmHg millimetres of Mercury (measurement for blood pressure)

ml/min millilitres per minute

mmol/L millimoles per litre

mmol/mol millimoles per mole

NAFLD Non-Alcoholic Fatty Liver Disease

NAION Non-arteritic Anterior Ischaemic Optic Neuropathy

NG NICE Guideline

NHS National Health Service

NICE The National Institute for Health and Care Excellence

NNH Number Needed to Harm

NNT Number Needed to Treat

NRT Nicotine Replacement Therapy

NSAID Non-Steroidal Anti-Inflammatory Drugs

NTI National Therapeutic Indicator

NVP Nicotine Vapour Products

OGTT Oral Glucose Tolerance Test

OHS Obesity Hypoventilation Syndrome

OSA Obstructive Sleep Apnoea

PCOS Polycystic Ovary Syndrome

PCSK9 Proprotein Convertase Subtilisin/Kexin type 9

PGD Patient Group Direction

PHS Public Health Scotland

PVD Peripheral Vascular Disease

QRISK an online medical algorithm used to estimate an individual's percentage chance of developing cardiovascular disease (such as a heart attack or stroke) within the next 10 years

QYW Quit Your Way

SADMAN Acronym used for medicine types included in medicine sick day guidance

SBP Systolic Blood Pressure

SGLT-2 Sodium-Glucose Co-Transporter 2

SGLT-2i Sodium-Glucose Co-Transporter 2 inhibitor

SELECT SELECT trial - Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity - SELECT

SHAAP Scottish Health Action on Alcohol

SIGN Scottish Intercollegiate Guidelines Network

SIMD Scottish Index of Multiple Deprivation

SLWG Short Life Working Group

SMART Specific, Measurable, Achievable, Relevant and Time-bound

SMC Scottish Medicines Consortium

SPC Summary of Product Characteristics

STU Scottish Therapeutics Utility

SUMMIT SUMMIT trial - Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

T2D Type 2 Diabetes

TIA Transient Ischemic Attack

U&E Urea & Electrolyte Profile

U/L Units per Litre

ULN Upper Limit of Normal

UK United Kingdom

V2.0 Version 2.0

WHO World Health Organisation